Evidence map›Paper›PMID 38662916›Full record

ArticleScience (New York, N.Y.)2024

Repair of CRISPR-guided RNA breaks enables site-specific RNA excision in human cells.

Anna Nemudraia, Artem Nemudryi, Blake Wiedenheft

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Spligation enables programmable chimeric RNA generation in living cells.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Single-molecule live-cell RNA imaging with CRISPR-Csm.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anna Nemudraia *Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0002-4190-6306
Artem Nemudryi *Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0003-0121-1363
Blake WiedenheftDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0001-9297-5304
Montana State University · US

Funding

Structural and functional understanding of bacterial defense and viral counter defenseR35GM134867 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Blake A Wiedenheft · 2020 to 2026
$3.8M
CRISPR-based editing of RNA and cellular mechanisms that govern RNA repairR00AI171893 · NIAID · UNIVERSITY OF FLORIDA · PI NEMUDRYI, ARTEM ALEKSANDROVICH · 2024 to 2025
$493k
CRISPR-based editing of RNA and cellular mechanisms that govern RNA repairK99AI171893 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI NEMUDRYI, ARTEM ALEKSANDROVICH · 2022 to 2023
$276k
NIAID NIH HHS K99 AI171893NIAID NIH HHS R00 AI171893NIGMS NIH HHS R35 GM134867
6 · The paper itself

Abstract

Genome editing with CRISPR RNA-guided endonucleases generates DNA breaks that are resolved by cellular DNA repair machinery. However, analogous methods to manipulate RNA remain unavailable. We show that site-specific RNA breaks generated with type-III CRISPR complexes are repaired in human cells and that this repair can be used for programmable deletions in human transcripts to restore gene function. Collectively, this work establishes a technology for precise RNA manipulation with potential therapeutic applications.

Indexed as

CRISPR-Associated ProteinsCRISPR-Cas SystemsGene EditingRNARNA, Guide, CRISPR-Cas SystemsCyclophilinsDNA RepairEndonucleasesHEK293 CellsHumansProtein Deglycase DJ-1Streptococcus thermophilusCRISPR-Associated Proteinscyclophilin BCyclophilinsEndonucleasesPARK7 protein, humanProtein Deglycase DJ-1RNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID38662916
PMCPMC11175973
OpenAlexW4395447721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.